• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-155 通过抑制白细胞介素 2 诱导的 T 细胞激酶在格雷夫斯眼病眼眶成纤维细胞中发挥抗炎作用。

MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.

机构信息

Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.

Department of Ophthalmology, Severance Hospital, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

PLoS One. 2022 Aug 18;17(8):e0270416. doi: 10.1371/journal.pone.0270416. eCollection 2022.

DOI:10.1371/journal.pone.0270416
PMID:35980936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9387810/
Abstract

To investigate the role of microRNA (miR)-155 in inflammation in an in-vitro model of Graves' orbitopathy (GO). The expression levels of miR-155 were compared between GO and non-GO orbital tissues. The effects of inflammatory stimulation of interleukin (IL)-1β and tumour necrosis factor alpha (TNF-α) on miR-155 expression on GO and non-GO orbital fibroblasts (OFs) were investigated. The effects of miR-155 mimics and inhibitors of inflammatory proteins and IL-2-inducible T-cell kinase (ITK) expression were examined, along with those related to the knockdown of ITK with siITK transfection on inflammatory proteins. We also examined how ITK inhibitors affect miR-155 expression in GO and non-GO OFs. The expression levels of miR-155 were higher in GO orbital tissues than in non-GO tissue. The overexpression of miR-155 was induced by IL-1β and TNF-α in OFs from GO and non-GO patients. IL-1β-induced IL-6 (ICAM1) protein production was significantly reduced (increased) by miR-155 mimics and inhibitors. The mRNA and protein levels of ITK were downregulated by overexpressed miR-155 via miR-155 mimics. Knockdown of ITK via siITK transfection induced a decrease in the expression levels of ITK, IL-17, IL-6, IL-1β, and TNF-α protein. The expression of miR-155 was significantly downregulated by treatment with ITK inhibitors and Bruton's tyrosine kinase (BTK)/ITK dual inhibitors in a time-dependent manner. Our results indicated a potential relationship between miR-155 and ITK in the context of GO OFs. The overexpression of miR-155 repressed ITK expression and relieved inflammation. Thus, miR-155 appears to have anti-inflammatory effects in GO OFs. This discovery provides a new concept for developing GO treatment therapeutics.

摘要

为了探讨微小 RNA(miR)-155 在甲状腺眼病(GO)体外模型中的炎症作用。比较 GO 和非 GO 眼眶组织中 miR-155 的表达水平。研究了白细胞介素(IL)-1β和肿瘤坏死因子-α(TNF-α)对 GO 和非 GO 眼眶成纤维细胞(OFs)中 miR-155 表达的炎症刺激作用。检测了炎症蛋白和 IL-2 诱导的 T 细胞激酶(ITK)表达的 miR-155 模拟物和抑制剂的作用,以及用 siITK 转染对炎症蛋白进行 ITK 敲低的作用。我们还研究了 ITK 抑制剂如何影响 GO 和非 GO OFs 中的 miR-155 表达。GO 眼眶组织中的 miR-155 表达水平高于非 GO 组织。IL-1β 和 TNF-α 在 GO 和非 GO 患者的 OFs 中诱导 miR-155 的过表达。miR-155 模拟物和抑制剂显著降低(增加)了 IL-1β 诱导的 IL-6(ICAM1)蛋白的产生。通过 miR-155 模拟物过表达 miR-155 下调 ITK 的 mRNA 和蛋白水平。通过 siITK 转染敲低 ITK 诱导 ITK、IL-17、IL-6、IL-1β 和 TNF-α 蛋白的表达水平降低。用 ITK 抑制剂和 Bruton 酪氨酸激酶(BTK)/ITK 双重抑制剂处理可显著下调 miR-155 的表达,呈时间依赖性。我们的结果表明,miR-155 与 GO OFs 中的 ITK 之间存在潜在关系。miR-155 的过表达抑制 ITK 的表达并缓解炎症。因此,miR-155 在 GO OFs 中具有抗炎作用。这一发现为 GO 治疗提供了一个新的概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/16afa9f53ac6/pone.0270416.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/97e063b1f60a/pone.0270416.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/5bdc1be8dcb0/pone.0270416.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/deb027808d85/pone.0270416.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/77e927ea7227/pone.0270416.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/596b242d7749/pone.0270416.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/c356059224cb/pone.0270416.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/16afa9f53ac6/pone.0270416.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/97e063b1f60a/pone.0270416.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/5bdc1be8dcb0/pone.0270416.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/deb027808d85/pone.0270416.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/77e927ea7227/pone.0270416.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/596b242d7749/pone.0270416.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/c356059224cb/pone.0270416.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55e2/9387810/16afa9f53ac6/pone.0270416.g007.jpg

相似文献

1
MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.微小 RNA-155 通过抑制白细胞介素 2 诱导的 T 细胞激酶在格雷夫斯眼病眼眶成纤维细胞中发挥抗炎作用。
PLoS One. 2022 Aug 18;17(8):e0270416. doi: 10.1371/journal.pone.0270416. eCollection 2022.
2
Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy.选择性白细胞介素-2 诱导型酪氨酸激酶抑制剂对格雷夫斯眼病眼眶成纤维细胞的治疗作用。
Endocr J. 2024 Sep 2;71(9):851-861. doi: 10.1507/endocrj.EJ23-0729. Epub 2024 Jun 13.
3
Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy.依鲁替尼对格雷夫斯眼眶病小鼠模型炎症的影响。
Front Endocrinol (Lausanne). 2024 Aug 30;15:1420024. doi: 10.3389/fendo.2024.1420024. eCollection 2024.
4
Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.miR-146a在格雷夫斯眼眶病体外模型炎症调节中的作用
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4027-34. doi: 10.1167/iovs.16-19213.
5
Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.微小 RNA-146a 在调节格雷夫斯眼病眼眶成纤维细胞纤维化中的作用。
Br J Ophthalmol. 2018 Mar;102(3):407-414. doi: 10.1136/bjophthalmol-2017-310723. Epub 2017 Nov 3.
6
Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.格雷夫斯眼眶病患者眼眶成纤维细胞脂肪生成和炎症过程中的趋化因子表达
Korean J Ophthalmol. 2020 Jun;34(3):192-202. doi: 10.3341/kjo.2020.0002.
7
Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.伊布替尼(一种选择性布鲁顿酪氨酸激酶抑制剂)对格雷夫斯眼病患者眼眶成纤维细胞的治疗作用。
PLoS One. 2022 Dec 15;17(12):e0279060. doi: 10.1371/journal.pone.0279060. eCollection 2022.
8
Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an Model of Graves' Orbitopathy.双硫仑在格雷夫斯眼眶病模型中发挥抗脂肪生成、抗炎和抗纤维化治疗作用。
Thyroid. 2022 Mar;32(3):294-305. doi: 10.1089/thy.2021.0246. Epub 2021 Dec 31.
9
Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.从眶内、鼻腔和中央脂肪组织培养的人眼眶成纤维细胞的特征。
Br J Ophthalmol. 2021 Feb;105(2):290-296. doi: 10.1136/bjophthalmol-2018-313699. Epub 2019 Sep 5.
10
Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.成纤维细胞生长因子 10 与格雷夫斯眼病纤维化和炎症发病机制的关系。
PLoS One. 2021 Aug 12;16(8):e0255344. doi: 10.1371/journal.pone.0255344. eCollection 2021.

引用本文的文献

1
The miR-320a/PRDX3 Axis Alleviates the Oxidative Stress and Fibrotic Alterations in Fibroblasts in Thyroid Eye Disease.miR-320a/PRDX3轴减轻甲状腺眼病成纤维细胞中的氧化应激和纤维化改变。
Invest Ophthalmol Vis Sci. 2025 Jul 1;66(9):41. doi: 10.1167/iovs.66.9.41.
2
Comparative study of the effects of baicalin and probenecid on microRNA expression profiles in porcine aortic vascular endothelial cells infected by Glaesserella parasuis.黄芩苷与丙磺舒对副猪嗜血杆菌感染的猪主动脉血管内皮细胞中微小RNA表达谱影响的比较研究
BMC Vet Res. 2025 Apr 2;21(1):237. doi: 10.1186/s12917-025-04702-2.

本文引用的文献

1
Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.Wnt 信号通路抑制格雷夫斯眼病眼眶成纤维细胞的脂肪生成。
Br J Ophthalmol. 2022 Jul;106(7):1019-1027. doi: 10.1136/bjophthalmol-2020-316898. Epub 2021 Jun 30.
2
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.IL-2 诱导的酪氨酸激酶 ITK 及其抑制剂在疾病发病机制中的作用。
J Mol Med (Berl). 2020 Oct;98(10):1385-1395. doi: 10.1007/s00109-020-01958-z. Epub 2020 Aug 18.
3
MicroRNA-155 Suppresses the Translation of p38 and Impairs the Functioning of Dendritic Cells in Endometrial Cancer Mice.
微小RNA-155抑制p38的翻译并损害子宫内膜癌小鼠中树突状细胞的功能。
Cancer Manag Res. 2020 Apr 30;12:2993-3002. doi: 10.2147/CMAR.S240926. eCollection 2020.
4
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.Graves 眼病发病机制和非手术治疗的新见解。
Nat Rev Endocrinol. 2020 Feb;16(2):104-116. doi: 10.1038/s41574-019-0305-4. Epub 2019 Dec 30.
5
Immunological Aspects of Graves' Ophthalmopathy.格雷夫斯眼病的免疫学方面。
Biomed Res Int. 2019 Nov 12;2019:7453260. doi: 10.1155/2019/7453260. eCollection 2019.
6
Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.从眶内、鼻腔和中央脂肪组织培养的人眼眶成纤维细胞的特征。
Br J Ophthalmol. 2021 Feb;105(2):290-296. doi: 10.1136/bjophthalmol-2018-313699. Epub 2019 Sep 5.
7
MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.微小 RNA-27 抑制格雷夫斯眼病患者眼眶成纤维细胞的成脂分化。
PLoS One. 2019 Aug 15;14(8):e0221077. doi: 10.1371/journal.pone.0221077. eCollection 2019.
8
A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation.白细胞介素-2 诱导的 T 细胞激酶(ITK)在人 Foxp3+TREG 分化中的负调控作用。
PLoS One. 2019 Apr 25;14(4):e0215963. doi: 10.1371/journal.pone.0215963. eCollection 2019.
9
MicroRNA-155: A Master Regulator of Inflammation.miRNA-155:炎症的主调控因子。
J Interferon Cytokine Res. 2019 Jun;39(6):321-330. doi: 10.1089/jir.2018.0155. Epub 2019 Mar 20.
10
High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.高迁移率族蛋白 B1 与格雷夫斯眼病的炎症发病机制有关。
Thyroid. 2019 Jun;29(6):868-878. doi: 10.1089/thy.2018.0285. Epub 2019 May 14.